Expression of v-fms and c-fms in the Hemopoietic Cell Line FDC-P1

References

• Anderson S. J., Gonda M. A., Rettenmier C. W., Sherr C. J. Subcellular localisation of glycoproteins encoded by the viral oncogene v-fms. J. Virol. 1984; 51: 730–741
   PubMedGoogle Scholar
• Austyn J. M., Gordon S. F4/80, a monoclonal antibody directed specificity against the mouse macrophage. Eur. J. Immunol. 1981; 11: 805–815
   PubMed Web of Science ®Google Scholar
• Bhattacharya A., Dorf M. E., Springer T. A. A shared alloantigenic determinant on ia antigens encoded by the I-A and I-E subregions: evidence for 1 region gene duplication. J. Immunol. 1981; 127: 2486–2495
   Google Scholar
• Clark S. C., Kamen R. The human hematopoietic colony-stimulating factors. Science 1987; 236: 1229–1237
   PubMed Web of Science ®Google Scholar
• Coussens L., Van Beveren C., Smith D., Chen E., Mitchell R. L., Isacke C. M., Verma I. M., Ullrich A. Structural alterations of viral homologue of receptor proto-oncogene fms at carboxyl terminus. Nature 1986; 320: 277–280
   PubMed Web of Science ®Google Scholar
• Crocker P. R., Gordon S. Mouse macrophage hemagglutinin (sheep erythrocyte receptor) with specificity for sialylated glycoconjugates characterized by a monoclonal antibody. J. Exp. Med. 1989; 169: 1333–1346
   PubMed Web of Science ®Google Scholar
• Dean M., Cleveland J. L., Rapp U. R., Ihle J. N. Role of myc in the abrogation of IL-3 dependence of FDC-P1 cells. Oncogene Res. 1987; 1: 279–296
   PubMedGoogle Scholar
• Dexter T. M., Spooncer E. Growth and differentiation in the hemopoietic system. Annu. Rev. Cell Biol. 1987; 3: 423–441
   PubMedGoogle Scholar
• Dexter T. M., Garland J., Scott D., Scolnick E., Metcalf D. Growth of factor-dependent hemopoietic precursor cell lines. J. Exp. Med. 1980; 152: 1036–1047
   PubMed Web of Science ®Google Scholar
• Dialynas D. P., Wilde D. B., Marrack P., Pierres A., Wall K. A., Havran W., Otten G., Loken M. R., Pierres M., Kappler J., Fitch F. W. Characterization of the murine antigenic determinant, designated L3T4a, recognised by monoclonal antibody GK1.5. Immunol. Rev. 1983; 74: 29–56
   PubMed Web of Science ®Google Scholar
• Donner L., Fedele L. A., Garon C. F., Anderson S. J., Sherr C. J. McDonough feline sarcoma virus: characterization of the molecularly cloned provirus and its feline oncogene (v-fms). J. Virol. 1982; 41: 489–500
   PubMed Web of Science ®Google Scholar
• Furman W. L., Rettenmier C. W., Chen J. H., Roussel M. F., Quinn C. O., Sherr C. J. Antibodies to distal carboxyl terminal epitopes in the v-fms-coded glycoprotein do not cross-react with the c-fms gene product. Virology 1986; 152: 432–445
   PubMed Web of Science ®Google Scholar
• Green S. M., Lowe A. D., Parrington J., Karn J. Transformation of growth factor-dependent myeloid stem cells with retroviral vectors carrying c-myc. Oncogene 1989; 4: 737–751
   PubMed Web of Science ®Google Scholar
• Greenberger J. S., Sakakeeny M. A., Humphries R. K., Eaves C. J., Eckner R. J. Demonstration of permanent factor-dependent multipotential (erythroid/neutrophil/basophil) haematopoietic progenitor cell lines. Proc. Natl. Acad. Sci. USA 1983; 80: 2931–2935
   PubMed Web of Science ®Google Scholar
• Hapel A. J., Warren H. S., Hume D. A. Different colony-stimulating-factors are detected by ‘interleukin-3′-dependent cell lines. FDC-P1 and 32D cl-23. Blood 1984; 64: 786–790
   PubMed Web of Science ®Google Scholar
• Hariharan I. K., Adams J. M., Cory S. bcr-abl oncogene renders myeloid cell line factor independent: potential autocrine mechanism in chronic myeloid leukemia. Oncogene Res. 1988; 3: 387–399
   PubMedGoogle Scholar
• Holden H. T., Lichter W., Siegel M. N. Quantitative methods for measuring cell growth and death. Tissue Culture, Methods and Applications, P. F. Kruse, M. K. Patterson. Academic Press. 1973; 408–412
   Google Scholar
• Karn J., Watson J. V., Lowe A. D., Green S. M., Vedeckis W. Regulation of cell cycle duration by c-myc levels. Oncogene 1989; 4: 773–878
   PubMed Web of Science ®Google Scholar
• Kawasaki E. S., Ladner M. B., Wang A. M., Arsdell J. V., Warren M. K., Coyne M. Y., Schweickart V. L., Lee M.-T., Wilson K. J., Boosman A., Stanley E. R., Ralph P., Mark D. F. Molecular cloning of a complementary DNA encoding human macrophage-specific colony-stimulating factor (CSF-1). Science 1985; 230: 291–296
   PubMed Web of Science ®Google Scholar
• Koch G., Smith M., Macer D., Webster P., Mortara R. Endoplasmic reticulum contains a common, abundant calcium-binding glycoprotein, endoplasmin. J. Cell Sci. 1986; 86: 217–232
   PubMed Web of Science ®Google Scholar
• Lyman S. D., Park L., Rohrschneider L. R. Colony stimulating-factor-1 induced growth stimulation of v-fms transformed fibroblasts. Oncogene 1988; 3: 391–395
   PubMed Web of Science ®Google Scholar
• Mann R., Mulligan R. C., Baltimore D. B. Construction of a retrovirus packaging mutant and its use to produce helper-free defective retrovirus. Cell 1983; 33: 153–159
   PubMed Web of Science ®Google Scholar
• McDonough S. K., Larsen S., Brodey R. S., Stock N. D., Hardy W. D., Jr. A transmissible feline fibrosarcoma of viral origin. Cancer Res. 1971; 31: 953–956
   PubMed Web of Science ®Google Scholar
• Metcalf D. The granulocyte-macrophage colony-stimulating factors. Science 1985; 229: 16–22
   PubMed Web of Science ®Google Scholar
• Metcalf D., Roberts T. M., Cherington V., Dunn A. R. The in vitro behaviour of hemopoietic cells transformed by polyoma middle T antigen parallels that of primary human myeloid leukemic cells. 1987
   Google Scholar
• Miller A. D., Buttimore C. Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production. Mol. Cell Biol. 1986; 6: 2895–2902
   PubMed Web of Science ®Google Scholar
• Morrison D. K., Browning P. J., White M. F., Roberts T. M. Tyrosine phosphorylations in vivo associated with v-fms transformation. Mol. Cell Biol. 1988; 8: 176–185
   PubMed Web of Science ®Google Scholar
• Nicola N. A. Why do hemopoietic growth factor receptors interact with each other?. Immunol. Today 1987; 8: 134–139
   PubMedGoogle Scholar
• Pierce J. H., Ruggiero M., Fleming T. P., Di Flore P. P., Greenberger J. S., Varticouski L., Schlessinger J., Rovera G., Aaronson S. A. Signal transduction through the EGF receptor transfected in IL-3-dependent hematopoietic cells. Science 1988; 2: 628–630
   Google Scholar
• Rosen H., Gordon S. Monoclonal antibody to the murine type 3 complement receptor inhibits adhesion of myelomonocytic cells in vitro and inflammatory cell recruitment in vivo. J. Exp. Med. 1987; 81: 115–129
   Google Scholar
• Rothwell V. M., Rohrschneider L. R. Murine c-fms cDNA: cloning, sequence analysis and retroviral expression. Oncogene Res. 1987; 1: 311–324
   PubMedGoogle Scholar
• Roussel M. F., Rettenmier C. W., Look A. T., Sherr C. J. Cell surface expression of v-fms-coded glycoprotein is required for transformation. Mol. Cell Biol. 1984; 4: 1999–2009
   PubMed Web of Science ®Google Scholar
• Roussel M. F., Dull T. J., Rettenmier C. W., Ralph P., Ullrich A., Sherr C. J. Transforming potential of the c-fms proto-oncogene (CSF-1 receptor). Nature 1987; 325: 549–552
   PubMed Web of Science ®Google Scholar
• Roussel M. F., Downing J. R., Rettenmier C. W., Sherr C. J. A point mutation in the extracellular domain of the human CSF-1 receptor (c-fms proto-oncogene product) activates its transforming potential. Cell 1988; 55: 979–988
   PubMed Web of Science ®Google Scholar
• von Ruden T., Wagner E. F. Expression of functional human EGF receptor on murine bone marrow cells. EMBO J. 1988; 7: 2794–2756
   Web of Science ®Google Scholar
• Sacca R., Stanley E. R., Sherr C. J., Rettenmier C. W. Specific binding of the mononuclear phagocyte colony-stimulating factor CSF-1 to the product of the v-fms oncogene. Proc. Natl. Acad. Sci. USA 1986; 83: 3331–3335
   PubMed Web of Science ®Google Scholar
• Sherr C. J., Rettenmier C. W., Sacca R., Roussel M. F., Look A. T., Stanley E. R. The c-fms proto-oncogene product is related to the receptor for the mononuclear phagocyte growth factor, CSF-1. Cell 1985; 41: 665–676
   PubMed Web of Science ®Google Scholar
• Springer T. A. Monoclonal antibody analysis of complex biological systems. J. Biol. Chem. 1981; 256: 3833–3839
   PubMed Web of Science ®Google Scholar
• Springer T. A., Galfre G., Secher D. S., Milstein C. Mac-1: a macrophage differentiation antigen identified by a monoclonal antibody. Eur. J. Immunol. 1979; 9: 301–306
   PubMed Web of Science ®Google Scholar
• Steinman R. M., Nogueira N., Witmer M. D., Tydings J. D., Mellman I. S. Lymphokine enhances the expression and synthesis of la antigens on cultured mouse peritoneal macrophages. 1980
   Google Scholar
• Wheeler E. F., Rettenmier C. W., Look A. T., Sherr C. J. The v-fms oncogene induces factor independence and tumorigenicity in CSF-1 dependent macrophage cell line. Nature 1986; 324: 377–380
   PubMed Web of Science ®Google Scholar
• Wheeler E. F., Askew D., May S., Ihle J. N., Sherr C. J. The v-fms oncogene induces factor-independent growth and transformation of the interleukin-3-dependent myeloid cell line FDC-P1. Mol. Cell Biol. 1987; 7: 1673–1680
   PubMed Web of Science ®Google Scholar
• Whetton A. D., Dexter T. M. Haemopoietic growth factors. TIBS 1986; 11: 207–211
   Web of Science ®Google Scholar
• Whetton A. D., Bazill G. W., Dexter T. M. Haemopoietic growth factor mediates cell survival via its action on glucose transport. EMBO J. 1984; 3: 409–413
   PubMed Web of Science ®Google Scholar
• Whetton A. D., Monk P. N., Consalvey S. D., Huang S. J., Dexter T. M., Downes C. P. Interleukin-3 stimulates proliferation via protein kinase C activation without increasing inositol lipid turnover. Proc. Natl. Acad. Sci. USA 1988; 85: 3284–3288
   PubMed Web of Science ®Google Scholar
• Woolford J., McAuliffe A., Rohrscheider L. R. Activation of the feline c-fms proto-oncogene: multiple alterations are required to generate a fully transformed phenotype. Cell 1988; 55: 965–977
   PubMed Web of Science ®Google Scholar